Posted by Michael Wonder on 28 Mar 2023
Clarification on the subsidy limitation for drugs for diabetes
28 March 2023 - The TLV has clarified the subsidy limitation for all GLP-1 receptor agonists.
This means that it is now clear that only patients with type 2 diabetes mellitus will receive a subsidy for these medicines and that they are not subsidised for weight loss in obese patients without type 2 diabetes mellitus.
